unknown
Stage
2019
Founded
3
Investors
About
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics that selectively target and deplete pathogenic cells for the treatment of cancer and autoimmune diseases.
Explore Dren Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.